Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_assertion type Assertion NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_head.
- NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_provenance.
- NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_assertion evidence source_evidence_literature NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_provenance.
- NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_assertion SIO_000772 16645590 NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_provenance.
- NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_assertion wasDerivedFrom befree-20150227 NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_provenance.
- NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_assertion wasGeneratedBy ECO_0000203 NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_provenance.